SEC Form D · filed April 3, 2024
NLS Pharmaceutics Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
Eric A. Konofal · Zurich, V8ExecAlexander Zwyer · Zurich, V8Exec · DirectorGian-Marco L. Rinaldi · Zurich, V8DirectorFlorence A. Aknin · Zurich, V8DirectorElena Thyen-Pighin · Zurich, V8ExecRonald Hafner · Zurich, V8DirectorClaudio L. Bassetti · Zurich, V8DirectorAudrey L. Greenberg · Zurich, V8DirectorEric A. Konofal · Zurich, V8ExecGeorge Apostol · Zurich, V8ExecAnthony Walsh · West Vancouve, British Columbia, CanadaDirectorPeter Lombardi · FOREST GROVE, ORExecGeorge Apostol · Zurich, V8ExecAnthony Walsh · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗